FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to com ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ...

Former President Donald Trump was given plenty of chances at last week’s debate to declare that he’d veto a national abortion ...

Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial.

The National Agency for Food and Drug Administration and Control (NAFDAC), has directed the closure of the Gomboru drug ...

GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help ...

Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...

ASX health stocks have fallen this week but Morgans analyst Scott Power is more optimistic after the Fed cut the cash rate by ...

Although tonight is football Friday, Barnesville Exempted Village School District Superintendent Micha Fuchs called an ...

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of ...

Two recent surveys of consumers show record lows in confidence of the safety of the U.S. food supply. In a Gallup poll, 28 ...

Sen. Bernie Sanders has frequently proposed "Medicare for all," a type of National Health Service for the U.S. If it isn’t ...